Chemokines: A new class of neuromodulator?

Nature Reviews Neuroscience

Volumn 8, Issue 11, 2007, Pages 895-904

  Rostène, William ^a   Kitabgi, Patrick ^a   Parsadaniantz, Stéphane Mélik ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE CCL22; CHEMOKINE RECEPTOR; CX3CL1 CHEMOKINE; CXCL2 CHEMOKINE; EOTAXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROHORMONE; NEUROPEPTIDE; NEUROTRANSMITTER; RANTES; STROMAL CELL DERIVED FACTOR 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; BRAIN; BRAIN DEVELOPMENT; CELL SURVIVAL; DRUG EFFECT; ELECTROPHYSIOLOGY; GLIA CELL; HORMONE ACTION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MEMBRANE DEPOLARIZATION; NERVE CELL; NEUROANATOMY; NEUROMODULATION; NEUROSCIENCE; NEUROTRANSMITTER RELEASE; NONHUMAN; PHYSIOLOGY; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESEARCH; REVIEW;

ANIMALS; BRAIN; CHEMOKINES; HUMANS; NEUROSECRETORY SYSTEMS; NEUROTRANSMITTER AGENTS; RECEPTORS, CHEMOKINE;

EID: 35549006675     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn2255     Document Type: Review

References (96)

1. Besedovsky, H. O. & del Rey, A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr. Rev. 17, 64-102 (1996).
2. Banks, W. A. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr. Pharm. Des. 11, 973-984 (2005).
3. Greter, M. et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nature Med. 11, 328-334 (2005).
4. Tambur, A. R. & Roitberg, B. Immunology of the central nervous system. Neurol. Res. 27, 675-678 (2005).
5. Yoshimura, T. et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl Acad. Sci. USA 84, 9233-9237 (1987).
6. Rossi, D. & Zlotnik, A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217-242 (2000).
7. Berger, E. A., Murphy, P. M. & Farber, J. M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17, 657-700 (1999).
8. Mennicken, F., Maki, R., de Souza, E. B. & Quirion, R. Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol. Sci. 20, 73-78 (1999).
9. Ubogu, E. E., Cossoy, M. B. & Ransohoff, R. M. The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 27, 48-55 (2006).
10. Proudfoot, A. E., Shaw, J. P., Power, C. A. & Wells, T. N. C. in Universes in Delicate Balance: Chemokines and the Nervous System (eds Ransohoff, R. M., Suzuki, K., Proudfoot, A. E. I., Hickey W. F. & Harrison, J. K.) 65-86 (Elsevier, Amsterdam, 2002).
11. Bajetto, A., Bonavia, R., Barbero, S., Florio, T. & Schettini, G. Chemokines and their receptors in the central nervous system. Front. Neuroendocrinol. 22, 147-184 (2001).
12. Tran, P. B. & Miller, R. J. Chemokine receptors in the brain: a developing story. J. Comp. Neurol. 457, 1-6 (2003).
13. Banisadr, G., Rostene, W., Kitabgi, P. & Parsadaniantz, S. M. Chemokines and brain functions. Curr. Drug Targets Inflamm. Allergy 4, 387-399 (2005).
14. White, F. A., Bhangoo, S. K. & Miller, R. J. Chemokines: integrators of pain and inflammation. Nature Rev. Drug Discov. 4, 834-844 (2005).
15. Bacon, K. B. & Harrison, J. K. Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis. J. Neuroimmunol. 104, 92-97 (2000).
16. Miller, R. J. & Oh, S. B. in Universes in Delicate Balance: Chemokines and the Nervous System (eds Ransohoff, R. M., Suzuki, K., Proudfoot, A. E. I., Hickey W. F. & Harrison, J. K.) 273-288 (Elsevier, Amsterdam, 2002).
17. Harrison, J. K. in Universes in Delicate Balance: Chemokines and the Nervous System (eds Ransohoff, R. M., Suzuki, K., Proudfoot, A. E. I., Hickey W. F. & Harrison, J. K.) 237-244 (Elsevier, Amsterdam, 2002).
18. Mahad, D. J. & Ransohoff, R. M. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin. Immunol. 15, 23-32 (2003).
19. Fife, B. T., Huffnagle, G. B., Kuziel, W. A. & Karpus, W. J. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 899-905 (2000).
20. White, F. A. et al. Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc. Natl Acad. Sci. USA 102, 14092-14097 (2005).
21. Banisadr, G. et al. Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J. Comp. Neurol. 489, 275-292 (2005).
22. Coughlan, C. M. et al. Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 97, 591-600 (2000).
23. Meng, S. Z., Oka, A. & Takashima, S. Developmental expression of monocyte chemoattractant protein-1 in the human cerebellum and brainstem. Brain Dev. 21, 30-35 (1999).
24. Banisadr, G. et al. Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons. J. Comp. Neurol. 492, 178-192 (2005).
25. Gosselin, R. D. et al. Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. J. Neurochem. 95, 1023-1034 (2005).
26. Tham, T. N. et al. Developmental pattern of expression of the alpha chemokine stromal cell-derived factor 1 in the rat central nervous system. Eur. J. Neurosci. 13, 845-856 (2001).
27. Banisadr, G., Skrzydelski, D., Kitabgi, P., Rostene, W. & Parsadaniantz, S. M. Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur. J. Neurosci. 18, 1593-1606 (2003).
28. Stumm, R. K. et al. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoformselective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J. Neurosci. 22, 5865-5878 (2002).
29. Xia, M. Q. & Hyman, B. T. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J. Neurovirol. 5, 32-41 (1999).
30. Harrison, J. K. et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl Acad. Sci. USA 95, 10896-10901 (1998).
31. Rotsztejn, W., Besson, J., Pattou, E. & Drouva, S. V. Hypothalamic neuropeptides (NP) can be neurotransmitters, neurohormones or neuromodulators. Adv. Physiol. Sci. 14, 217-229 (1981).
32. de Jong, E. K. et al. Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. J. Neurosci. 25, 7548-7557 (2005).
33. Callewaere, C. et al. Cellular and subcellular evidence for neuronal interaction between the chemokine SDF-1/CXCL12 and vasopressin: regulation in the hypothalamo-neurohypophysial system of the Brattleboro rats. Endocrinology 27 Sep 2007 (doi:10.1210/en.2007-1097).
34. Callewaere, C. et al. The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4. Proc. Natl Acad. Sci. USA 103, 8221-8226 (2006).
35. Baudouin, S. J., Pujol, F., Nicot, A., Kitabgi, P. & Boudin, H. Dendrite-selective redistribution of the chemokine receptor CXCR4 following agonist stimulation. Mol. Cell. Neurosci. 33, 160-169 (2006).
36. Oh, S. B., Cho, C. & Miller, R. J. Electrophysiological analysis of neuronal chemokine receptors. Methods 29, 335-344 (2003).
37. Guyon, A., Rovere, C., Cervantes, A., Allaeys, I. & Nahon, J. L. Stromal cell-derived factor-1α directly modulates voltage-dependent currents of the action potential in mammalian neuronal cells. J. Neurochem. 93, 963-973 (2005).
38. Guyon, A. et al. Complex effects of stromal cell-derived factor-1α on melanin-concentrating hormone neuron excitability. Eur. J. Neurosci. 21, 701-710 (2005).
39. Guyon, A. et al. Stromal cell-derived factor-1α modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms. J. Neurochem. 96, 1540-1550 (2006).
40. Limatola, C. et al. SDF-1α-mediated modulation of synaptic transmission in rat cerebellum. Eur. J. Neurosci. 12, 2497-2504 (2000).
41. Ragozzino, D., Renzi, M., Giovannelli, A. & Eusebi, F. Stimulation of chemokine CXC receptor 4 induces synaptic depression of evoked parallel fibers inputs onto Purkinje neurons in mouse cerebellum. J. Neuroimmunol. 127, 30-36 (2002).
42. Oh, S. B., Endoh, T., Simen, A. A., Ren, D. & Miller, R. J. Regulation of calcium currents by chemokines and their receptors. J. Neuroimmunol. 123, 66-75 (2002).
43. Jazin, E. E., Soderstrom, S., Ebendal, T. & Larhammar, D. Embryonic expression of the mRNA for the rat homologue of the fusin/CXCR-4 HIV-1 coreceptor. J. Neuroimmunol. 79, 148-154 (1997).
44. McGrath, K. E., Koniski, A. D., Maltby, K. M., McGann, J. K. & Palis, J. Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev. Biol. 213, 442-456 (1999).
45. Tissir, F., Wang, C. E. & Goffinet, A. M. Expression of the chemokine receptor Cxcr4 mRNA during mouse brain development. Brain Res. Dev. Brain Res. 149, 63-71 (2004).
46. Westmoreland, S. V. et al. Developmental expression patterns of CCR5 and CXCR4 in the rhesus macaque brain. J. Neuroimmunol. 122, 146-158 (2002).
47. Banisadr, G. et al. Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur. J. Neurosci. 16, 1661-1671 (2002).
48. Stumm, R. K. et al. CXCR4 regulates interneuron migration in the developing neocortex. J. Neurosci. 23, 5123-5130 (2003).
49. Skrzydelski, D. et al. The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J. Neurochem. 102, 1175-1183 (2007).
50. Ludwig, M. et al. Regulation of activity-dependent dendritic vasopressin release from rat supraoptic neurones. J. Physiol. 564, 515-522 (2005).
51. 3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl Acad. Sci. USA 97, 8075-8080 (2000).
52. Goldberg, S. H. et al. CXCR3 expression in human central nervous system diseases. Neuropathol. Appl. Neurobiol. 27, 127-138 (2001).
53. Horuk, R. et al. Expression of chemokine receptors by subsets of neurons in the central nervous system. J. Immunol. 158, 2882-2890 (1997).
54. 2+ currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J. Neurochem. 78, 960-971 (2001).
55. Streit, W. J., Conde, J. R. & Harrison, J. K. Chemokines and Alzheimer's disease. Neurobiol. Aging 22, 909-913 (2001).
56. Wells, T. N., Power, C. A. & Proudfoot, A. E. Definition, function and pathophysiological significance of chemokine receptors. Trends Pharmacol. Sci. 19, 376-380 (1998).
57. Abbadie, C. Chemokines, chemokine receptors and pain. Trends Immunol. 26, 529-534 (2005).
58. Biber, K., de Jong, E. K., van Weering, H. R. & Boddeke, H. W. Chemokines and their receptors in central nervous system disease. Curr. Drug Targets. 7, 29-46 (2006).
59. Rogers, T. J., Steele, A. D., Howard, O. M. & Oppenheim, J. J. Bidirectional heterologous desensitization of opioid and chemokine receptors. Ann. NY Acad. Sci. 917, 19-28 (2000).
60. Szabo, I. et al. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc. Natl Acad. Sci. USA 99, 10276-10281 (2002).
61. Zhang, N., Rogers, T. J., Caterina, M. & Oppenheim, J. J. Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize μ-opioid receptors on dorsal root ganglia neurons. J. Immunol. 173, 594-599 (2004).
62. Liu, Q. H. et al. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. Proc. Natl Acad. Sci. USA 97, 4832-4837 (2000).
63. 2+ spikes in cultured hippocampal networks through G-protein-coupled receptors. J. Neurosci. 23, 4156-4163 (2003).
64. Pujol, F., Kitabgi, P. & Boudin, H. The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons. J. Cell Sci. 118, 1071-1080 (2005).
65. Bajetto, A. et al. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J. Neurochem. 73, 2348-2357 (1999).
66. Ma, Q. et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4-and SDF-1-deficient mice. Proc. Natl Acad. Sci. USA 95, 9448-9453 (1998).
67. Zhu, Y. et al. Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons. Nature Neurosci. 5, 719-720 (2002).
68. Lu, M., Grove, E. A. & Miller, R. J. Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc. Natl Acad. Sci. USA 99, 7090-7095 (2002).
69. Tran, P. B., Ren, D., Veldhouse, T. J. & Miller, R. J. Chemokine receptors are expressed widely by embryonic and adult neural progenitor cells. J. Neurosci. Res. 76, 20-34 (2004).
70. Bagri, A. et al. The chemokine SDF1 regulates migration of dentate granule cells. Development 129, 4249-4260 (2002).
71. Arakawa, Y. et al. Control of axon elongation via an SDF-1α/Rho/mDia pathway in cultured cerebellar granule neurons. J. Cell Biol. 161, 381-391 (2003).
72. Chalasani, S. H., Sabelko, K. A., Sunshine, M. J., Littman, D. R. & Raper, J. A. A chemokine, SDF-1, reduces the effectiveness of multiple axonal repellents and is required for normal axon pathfinding. J. Neurosci. 23, 1360-1371 (2003).
73. Bolin, L. M. et al. Primary sensory neurons migrate in response to the chemokine RANTES. J. Neuroimmunol. 81, 49-57 (1998).
74. Belmadani, A. et al. The chemokine stromal cell-derived factor-1 regulates the migration of sensory neuron progenitors. J. Neurosci. 25, 3995-4003 (2005).
75. Lazarini, F., Tham, T. N., Casanova, P., Arenzana-Seisdedos, F. & Dubois-Dalcq, M. Role of the α-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 42, 139-148 (2003).
76. Meucci, O. et al. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl Acad. Sci. USA 95, 14500-14505 (1998).
77. Watson, K. & Fan, G. H. Macrophage inflammatory protein 2 inhibits β-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Mol. Pharmacol. 67, 757-765 (2005).
78. Limatola, C. et al. The chemokine growth-related gene product β protects rat cerebellar granule cells from apoptotic cell death through ?-amino-3-hydroxy-5-met hyl-4-isoxazolepropionate receptors. Proc. Natl Acad. Sci. USA 97, 6197-6201 (2000).
79. Wee, V. W. in Universes in Delicate Balance: Chemokines and the Nervous System (eds Ransohoff, R. M., Suzuki, K., Proudfoot, A. E. I., Hickey W. F. & Harrison, J. K.) 151-158 (Elsevier, Amsterdam, 2002).
80. Vergote, D. et al. Proteolytic processing of SDF-1α reveals a change in receptor specificity mediating HIV-associated neurodegeneration. Proc. Natl Acad. Sci. USA 103, 19182-19187 (2006).
81. Boudin, H., Pelaprat, D., Rostene, W., Pickel, V. M. & Beaudet, A. Correlative ultrastructural distribution of neurotensin receptor proteins and binding sites in the rat substantia nigra. J. Neurosci. 18, 8473-8484 (1998).
82. Agnati, L. F. et al. Volume transmission and wiring transmission from cellular to molecular networks: history and perspectives. Acta Physiol. 187, 329-344 (2006).
83. Sakamoto, Y. et al. Endotoxin activates a chemokinergic neuronal pathway in the hypothalamopituitary system. Endocrinology 137, 4503-4506 (1996).
84. Florio, T. et al. Chemokine stromal cell-derived factor 1α induces proliferation and growth hormone release in GH4C1 rat pituitary adenoma cell line through multiple intracellular signals. Mol. Pharmacol. 69, 539-546 (2006).
85. Rostene, W. & Buckingham, J. C. Chemokines as modulators of neuroendocrine functions. J. Mol. Endocrinol. 38, 351-353 (2007).
86. Guyon, A. & Nahon, J. L. Multiple actions of the chemokine stromal cell-derived factor-1α on neuronal activity. J. Mol. Endocrinol. 38, 365-376 (2007).
87. Barbieri, F. et al. Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function. J. Mol. Endocrinol. 38, 383-389 (2007).
88. Callewaere, C., Banisadr, G., Rostene, W. & Parsadaniantz, S. M. Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulation. J. Mol. Endocrinol. 38, 355-363 (2007).
89. Tanaka, T., Minami, M., Nakagawa, T. & Satoh, M. Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci. Res. 48, 463-469 (2004).
90. Abbadie, C. et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl Acad. Sci. USA 100, 7947-7952 (2003).
91. Giovannelli, A. et al. CXC chemokines interleukin-8 (IL-8) and growth-related gene product α (GROα) modulate Purkinje neuron activity in mouse cerebellum. J. Neuroimmunol. 92, 122-132 (1998).
92. Betancur, C., Azzi, M. & Rostene, W. Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy. Trends Pharmacol. Sci. 18, 372-386 (1997).
93. Brodmerkel, C. M. et al. Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344. J. Immunol. 175, 5370-5378 (2005).
94. Zhang, Y., Ernst, C. A. & Rollins, B. J. MCP-1: structure/activity analysis. Methods 10, 93-103 (1996).
95. Crump, M. P. et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16, 6996-7007 (1997).
96. Ransohoff, R. M., Sukuzi, K., Proudfoot, A. E., Hickey, W. F. & Harrison, JK. (eds) Universes in Delicate Balance: Chemokines and the Nervous System 1-387 (Elsevier, Amsterdam, 2002).